Genky DrugStores Co Ltd
TSE:9267
Intrinsic Value
Genky DrugStores Co., Ltd. operates as a holding company which provides the management of its group companies that is engaged in the management of drug stores. [ Read More ]
The intrinsic value of one
Genky DrugStores Co Ltd
stock under the Base Case scenario is
6 419.44
JPY.
Compared to the current market price of 6 210 JPY,
Genky DrugStores Co Ltd
is
Undervalued by 3%.
Genky DrugStores Co Ltd's market capitalization is 94.3B JPY.
Genky DrugStores Co Ltd stock price is 6 210 JPY.
Genky DrugStores Co Ltd stock price (6210 JPY) is 3% less than its Intrinsic Value (6 419.44 JPY).
Genky DrugStores Co Ltd stock (6 140.56 JPY) is 1% less than its price (6210 JPY). Open DCF Valuation
Genky DrugStores Co Ltd stock price (6210 JPY) is 7% less than its Relative Value (6 698.33 JPY). Open Relative Valuation
Genky DrugStores Co Ltd has upside potential of 25% compared to the average analyst price target.
Open Wall St Estimates
Genky DrugStores Co Ltd's ROIC (Return on Invested Capital) has decreased in the last 3 years from 8% to 7%.
Genky DrugStores Co Ltd has negative Free Cash Flow for the last twelve months.
Genky DrugStores Co Ltd's ROE (Return on Equity) has decreased in the last 3 years from 16% to 14%.
Genky DrugStores Co Ltd's Revenue has grown by 9% over the past 12 months.
Genky DrugStores Co Ltd's ROE (Return on Equity) for the past 12 months is positive and is equal to 14%.
Genky DrugStores Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is positive and is equal to 7%.
Genky DrugStores Co Ltd's Revenue is forecast to grow at a rate of 9% per year over the next 3 years.
Genky DrugStores Co Ltd's short-term liabilties (38B JPY) exceed its short-term assets (35B JPY).
Genky DrugStores Co Ltd has positive three-year average ROE (Return on Equity): 14%. The company is efficient at transforming stockholders' equity into net income.
Genky DrugStores Co Ltd has positive three-year average ROIC (Return on Invested Capital): 7%. The company is efficient at using invested capital to generate operating income.
Genky DrugStores Co Ltd's Revenue has been growing by 9% per year for the last 3 years.
Genky DrugStores Co Ltd has positive Gross Profit for the last twelve months.
Genky DrugStores Co Ltd has positive Operating Income for the last twelve months.
Genky DrugStores Co Ltd has positive Net Income for the last twelve months.
Genky DrugStores Co Ltd's long-term assets (108B JPY) exceed its long-term liabilties (65B JPY).
Genky DrugStores Co Ltd's Altman Z-Score is equal to 3.
Genky DrugStores Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.53.
Genky DrugStores Co Ltd has positive Net Debt. This means that the company has more debt (23B JPY) than cash and short-term investments (4B JPY).
Genky DrugStores Co Ltd earns more than enough operating income (8B JPY) to safely cover interest payments on its debt (80m JPY).
Valuation Backtest
Genky DrugStores Co Ltd
Run backtest to discover the historical profit from buying and selling
Genky DrugStores Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Genky DrugStores Co Ltd
Balance Sheet Decomposition
Genky DrugStores Co Ltd
| Current Assets | 34.8B |
| Cash & Short-Term Investments | 4.1B |
| Receivables | 4B |
| Other Current Assets | 26.7B |
| Non-Current Assets | 73.5B |
| PP&E | 67.1B |
| Intangibles | 420m |
| Other Non-Current Assets | 6B |
| Current Liabilities | 37.6B |
| Accounts Payable | 22.7B |
| Accrued Liabilities | 132m |
| Short-Term Debt | 300m |
| Other Current Liabilities | 14.5B |
| Non-Current Liabilities | 27.1B |
| Long-Term Debt | 22.9B |
| Other Non-Current Liabilities | 4.1B |
Earnings Waterfall
Genky DrugStores Co Ltd
|
Revenue
|
177.2B
JPY
|
|
Cost of Revenue
|
-140.9B
JPY
|
|
Gross Profit
|
36.2B
JPY
|
|
Operating Expenses
|
-28.5B
JPY
|
|
Operating Income
|
7.7B
JPY
|
|
Other Expenses
|
-2.2B
JPY
|
|
Net Income
|
5.6B
JPY
|
Free Cash Flow Analysis
Genky DrugStores Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Genky DrugStores Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Score
Genky DrugStores Co Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Genky DrugStores Co Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Score
Genky DrugStores Co Ltd's solvency score is 63/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Genky DrugStores Co Ltd
According to Wall Street analysts, the average 1-year price target for
Genky DrugStores Co Ltd
is 7 752 JPY
with a low forecast of 7 373 JPY and a high forecast of 8 295 JPY.
Shareholder Return
Price
Genky DrugStores Co Ltd
| Average Annual Return | 16.97% |
| Standard Deviation of Annual Returns | 53.63% |
| Max Drawdown | -46% |
| Market Capitalization | 94.3B JPY |
| Shares Outstanding | 15 191 286 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Genky DrugStores Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Genky DrugStores Co., Ltd. operates as a holding company which provides the management of its group companies that is engaged in the management of drug stores. The company is headquartered in Sakai-Shi, Fukui-Ken and currently employs 1,501 full-time employees. The company went IPO on 2017-12-21. The firm is mainly engaged in the retail of medicines, cosmetics, miscellaneous goods, foods and others.
Contact
IPO
Employees
Officers
The intrinsic value of one
Genky DrugStores Co Ltd
stock under the Base Case scenario is
6 419.44
JPY.
Compared to the current market price of 6 210 JPY,
Genky DrugStores Co Ltd
is
Undervalued by 3%.
You don't have any saved screeners yet
